IMPLANET, TINAVI Medical Technologies Sign Distribution Deal for TiRobot Spine System

IMPLANET is accelerating its commercialization strategy for cobotic¹ solutions in orthopedic surgery by signing an exclusive distribution agreement with TINAVI Medical Technologies Co. Ltd. for the TiRobot spine surgery system.

“Following our partnership with Sanyou Medical and in line with our strategic plan, the signing of this exclusive distribution agreement with TINAVI Medical Technologies, a Chinese manufacturer and player in surgical robotics, strengthens IMPLANET’s positioning as a provider of comprehensive solutions for spine surgeons,” IMPLANET CEO Ludovic Lastennet stated. “This agreement also paves the way for the next stages in autonomous surgeon-assistance technologies, enabling more precise, faster procedures while enhancing patient safety.”

This commercial partnership between IMPLANET and TINAVI will foster the synergy of both groups’ technological and R&D expertise. It also strengthens IMPLANET’s product offering by incorporating the latest advances and innovations in spine surgery (including deformity treatment systems, minimally invasive ranges, robotics, and artificial intelligence, etc.).

TINAVI’s TiRobot was developed by surgeons, for surgeons. It is an autonomous cobot that is not fixed to the operating table, allowing the surgeon to make continuous adjustments throughout the procedure according to surgical needs and patient movements. The TiRobot provides an automated guidance system during surgery and can address most spinal pathology indications. Future updates will soon enable its use in other orthopedic surgical specialties such as hip, knee, and shoulder prosthesis implantation as well as in trauma surgery.

“In addition to the distribution agreements in China concluded with Sanyou Medical, we are delighted to sign this agreement with IMPLANET,” TINAVI Marketing and Business Development Director Kevin Liu added. “Combining robotics with IMPLANET’s implant offering will allow us to create synergies, making our two companies key players in the spine surgery market. “

TINAVI Medical Technologies Co. Ltd. is a Beijing-based group specializing in surgical systems and operating room solutions. Its third-generation intelligent orthopedic robot, TiRobot, reportedly is the world’s only surgical robot capable of performing procedures throughout the entire spine (cervical, thoracic, lumbar, and sacral vertebrae). Since 2020, the company has been listed on the SSE STAR market, Shanghai’s Science and Technology Innovation Market.

IMPLANET manufactures implants for orthopedic surgery and distributes medical technology equipment. Its activities focus on an innovative solution to improve spinal pathology treatment (JAZZ), complemented by the product range of thoraco-lumbar screws, cages, and cervical plates acquired through Orthopaedic & Spine Development (OSD) in May 2021. In 2022, the company entered into a commercial, technological, and financial partnership with Sanyou Medical, China’s second-largest medical device manufacturer. As part of this strategic agreement, IMPLANET developed in 2024 the JAZZ Spinal System hybrid fixation system, a new range featuring a comprehensive pedicle screw solution, combined with advanced braided implant technology, JAZZ. Protected by four families of international patents, JAZZ has received U.S. Food and Drug Administration 510(k) clearance, CE marking in Europe, and ANVISA approval in Brazil. IMPLANET employs 46 people and generated €9.4 million in consolidated 2024 revenue. Based near Bordeaux, France, IMPLANET has operated a U.S. subsidiary in Boston since 2013 and is listed on the Euronext Growth market in Paris.

Reference
¹ Human-robot collaboration